News
German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.
The pharmaceutical giant's journey with Celonis has evolved from operational efficiency to enabling enterprise AI ...
Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to persistent weakness in demand for the blockbuster human papillomavirus vaccine ...
Kai Beckmann, CEO of Electronics at Merck KGaA, discusses Europe's competitiveness in AI development.
Merck & Co., Inc. (NYSE: MRK) is one of the best depressed stocks to buy in 2025. On August 2, the company completed the ...
The veterinary care market offers opportunities driven by rising pet ownership, digital health adoption, advanced diagnostics ...
Before you buy stock in Merck, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Merck wasn’t one ...
The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted ...
A change in full-year guidance by management wasn't particularly welcome.
Key opportunities arise from personalized treatment growth, advances in sequencing technology, strategic alliances, adaptable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results